skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985–2008

Original Research

(1979) Views  (518) Full article downloads

Authors: Kåre E Bakkevold

Published Date June 2010 Volume 2010:3 Pages 71 - 77
DOI: http://dx.doi.org/10.2147/CEG.S10921

Kåre E Bakkevold

Department of Surgery, Haugesund Hospital, Haugesund, Norway

Objective: The aim of this study was to examine time trends in the incidence of peptic ulcer bleeding and risk factors in a defined geographical area in Norway.

Material and methods: Retrospective data were collected for 306 patients with bleeding peptic ulcers admitted to one hospital during the 1985–1986, 1995–1996, and 2007–2008 periods.

Results: The incidence in 1985–1986 was 52/100,000 and in 2007–2008 was 45/100,000. In the group aged 20–75 years, the incidence decreased by 54% from 54/100000 in 1985–1986 to 25/100000 in 2007–2008 (P = 0.001) and increased by 49% in the group aged >75 years from 272/100000 to 406/100000 (P = 0.0001). The use of aspirin or nonsteroidal anti-inflammatory steroid drugs (NSAIDs) was 31% in 1985–1986 and increased to 67% in 2007–2008 (P = 0.004). In patients using aspirin or NSAIDs, Helicobacter pylori was present in 73% in 1995–1996 and in 51% in 2007–2008. H. pylori infection declined from 84% to 52% between 1995–1996 and 2007–2008.

Conclusions: The incidence rate of peptic ulcer bleeding did not change between 1985–1986 and 2007–2008, but decreased in the age group ≤75 years and increased in the age group >75 years. The use of low-dose aspirin and NSAIDs increased substantially over time, and H. pylori infection was still present in 51% of these patients in 2007–2008.

Keywords: epidemiology, peptic ulcer bleeding, time trends, risk factors








Readers of this article also read:

Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective?
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Editorial
New and emerging treatments for the prevention of recurrent diverticulitis
Update on celiac disease – etiology, differential diagnosis, drug targets, and management advances
Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio